RNXT – renovorx, inc. (US:NASDAQ)
Stock Stats
News
RenovoRx Initiates Patient Enrollment at SCRI Oncology Partners for Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial in Locally Advanced Pancreatic Cancer
RenovoRx CEO to Host Investor Fireside Chat on Tuesday, December 17th at 4:30 p.m. ET [Yahoo! Finance]
RenovoRx, Inc. (NASDAQ: RNXT) had its price target raised by analysts at Ascendiant Capital Markets from $8.25 to $9.00. They now have a "buy" rating on the stock.
RenovoRx CEO to Host Investor Fireside Chat on Tuesday, December 17th at 4:30 p.m. ET
RenovoRx Receives First Purchase Orders for its FDA-Cleared RenovoCath® Delivery System [Yahoo! Finance]
Form 8-K RenovoRx, Inc. For: Nov 14
Form 10-Q RenovoRx, Inc. For: Sep 30
Form 4 RenovoRx, Inc. For: Oct 01 Filed by: Spiegel Robert J.
Form 4 RenovoRx, Inc. For: Oct 01 Filed by: Macfarlane K. Angela
Form 4 RenovoRx, Inc. For: Oct 01 Filed by: Marton Laurence
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.